SYNTHESIS OF (+/-)-TRANS-6-[4,4-BIS(4-FLUOROPHENYL)-3-(1-METHYL-1H-TETRAZOL-5-YL)-1(E),3-[2-C-14]BUTADIENYL]-4-HYDROXY-3,4,5,6-TETRAHYDRO-2H-PYRAN-2-ONE

被引:1
|
作者
LUKE, GM
SWIGOR, JE
机构
[1] Bristol-Myers Squibb, Pharmaceutical Research and Development Division, Syracuse, New York
关键词
(+/-)-TRANS-6-[4,4-BIS(4-FLUOROPHENYL)-3-(1-METHYL-1H-TETRAZOL-5-YL)-1(E),3-[2-; HMG-COA REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC;
D O I
10.1002/jlcr.2580290209
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A convergent synthesis of the title compound (BMY-22089) is described. [C-14]Methyl iodide was used to alkylate 1,5-dimethyltetrazole which was added to 4,4'-difluorobenzophenone to give the tertiary alcohol 4. Dehydration gave the olefin 5 which was brominated and converted to the phosphonate 7 with trimethylphosphite. Coupling of the carbanion of 7 with cis-2, 2-dimethyl-6-formyl-1,3-dioxane-4-acetic acid tert-butyl ester (8) produced the diene 9. Sequential hydrolysis steps using acid and base gave the dihydroxy acid 11 which was converted to the lactone 12 with the use of dicyclohexylcarbodiimide. The overall yield was 20%.
引用
收藏
页码:193 / 199
页数:7
相关论文
共 50 条
  • [21] 4-(4-Fluorophenyl)-3-(pyridin-4-yl)-1-(2,4,6-trichlorophenyl)-1H-pyrazol-5-amine
    Abu Thaher, Bassam
    Koch, Pierre
    Schollmeyer, Dieter
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O2603 - +
  • [22] 4-(4-fluorophenyl)-3-(4-pyridyl)quinolin-2(1H)-one
    Peifer, Christian
    Schollmeyer, Dieter
    Selig, Roland
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2006, 62 : O2648 - O2650
  • [23] 4-[5-Amino-4-(4-fluorophenyl)-3-(pyridin-4-yl)-1H-pyrazol-1-yl]benzonitrile
    Abu Thaher, Bassam
    Koch, Pierre
    Schollmeyer, Dieter
    Laufer, Stefan
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O935 - +
  • [24] 3-(4-fluorophenyl)-4-(4-pyridyl)quinolin-2(1H)-one
    Peifer, C
    Schollmeyer, D
    Laudage, S
    Laufer, S
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2006, 62 : O2475 - O2477
  • [25] 3-[4-(4-Fluorophenyl)piperazin-1-ylmethyl]-5-methyl-1,3-benzoxazol-2(3H)-one and 3-[4-(2-fluorophenyl)piperazin-1-ylmethyl]-5-methyl-1,3-benzoxazol-2 (3H)-one
    Köysal, Y
    Isik, S
    Köksal, M
    Erdogan, H
    Gokhan, N
    ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2004, 60 : O232 - O234
  • [26] THE SYNTHESIS AND EVALUATION OF TRANS-6-(SUBSTITUTED-1-NAPHTHYL)ETHYL(OR ETHENYL)-3,4,5,6-TETRAHYDRO-4-HYDROXY-2H-PYRAN-2-ONES AS INHIBITORS OF HMG-COA REDUCTASE
    PRUGH, JD
    ALBERTS, AW
    DEANA, AA
    GILFILLAN, JL
    HUFF, JW
    WIGGINS, JM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1987, 193 : 21 - MEDI
  • [27] (2R*,3R*,6S*)-N,6-Bis(4-fluorophenyl)-2-(4-hydroxy-phenyl)-3,4,5,6-tetrahydro-2H-pyran-3-carboxamide
    Swamy, GYSK
    Ravikumar, K
    Wadhwa, LK
    Saxena, R
    Singh, S
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2005, 61 : O3608 - O3610
  • [28] Crystal structure of (E)-2-(5-(4-fluorophenyl)-3-(furan-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)-5-((4-fluorophenyl)diazenyl)-4-methylthiazole, C23H17F2N5OS
    El-Hiti, Gamal A.
    Abdel-Wahab, Bakr F.
    Hegazy, Amany S.
    Kariuki, Benson M.
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2017, 232 (03): : 413 - 415
  • [29] 3-(4-Fluorophenyl)-1-(1-(4-fluorophenyl)-3,3,3-trifluoroprop-1-en-1-yl)-5-fluoro-1H-pyrazole
    Paveliev, Stanislav A.
    Ustyuzhanin, Alexander O.
    Krylov, Igor B.
    Terent'ev, Alexander O.
    MOLBANK, 2023, 2023 (02)
  • [30] Crystal structure and DFT studies of (E)-1-(4-fluorophenyl)-3-(1H-indol-1-yl)-4-styrylazetidin-2-one
    Gummidi, Lalitha
    Kerru, Nagaraju
    Ibeji, Collins U.
    Singh, Parvesh
    JOURNAL OF MOLECULAR STRUCTURE, 2019, 1187 : 50 - 58